An observational study in Burns, Critical Illness and Indirect Calorimetry, sponsored by University of Liege. Recruiting at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-06-27.
Sponsored by University of Liege · Observational
Burn patients treated in an outpatient clinic and ICU survivors are at risk of malnutrition. There are no clear guidelines determining the energy target in those two populations. The aim of this observation study is to measure the resting energy expenditure of those patients, using indirect calorimetry.
1,587 studies on the registry are indexed under Malnutrition; 237 are open to participants now.
This study's planned enrollment of 100 is below the median of 203 across 388 observational studies indexed under Malnutrition.
Browse Malnutrition studies →University of Liege is the lead sponsor of 242 studies on the registry; 46 are open to participants now.
Counted across the registry records on this site, refreshed daily.
the study population is divided into two groups: burn patients with minor burn exclusively treated in an outpatient setting, and ICU survivors who were discharged fro ICU after a stay of at least 7 days
Exclusion Criteria:
Burn patients treated for minor burns in an outpatient setting
Diagnostic Test: indirect calorimetry
Critically ill patients who survived ICU stay and are admitted in a general ward
Diagnostic Test: indirect calorimetry
measurement of resting energy expenditure using indirect calorimetry
resting energy expenditure
Time frame: during the 7 days following injury in burn patients or following ICU discharge in ICU survivors
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Liege